AzTrials
AzTrials

Ileostomy - StomaNCT02064231

A Clinical Investigation Examining the Performance and Handling of New 2-piece Ostomy Products in 28 People With an Ileostomy.

A study testing Coloplast Test A, Coloplast Test B and Own product in people with Ileostomy - Stoma, run by Coloplast A/S.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To assess the functionality and safety of the test products and also assess the products ability to collect stool without interfering with the stoma. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Ileostomy - Stoma
What is being tested?
Coloplast Test A, Coloplast Test B and Own product
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
28 participants
Where
No sites listed yet
Study dates
Jun 2012to Aug 2012
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Had given written informed consent
  • Was at least 18 years of age
  • Was able to handle the appliances themselves or with help from a caregiver (e.g. spouse)
  • Had an ileostomy with a diameter between 15-45 mm
  • Have had an ileostomy for at least 3 months
  • Currently used a 2-piece flat appliance

Who cannot join

  • Used irrigation during the investigation (flush stoma with water)
  • Currently received or had within the past 2 months received radio- and/or chemotherapy.
  • Currently received or had within the past month received local or systemic steroid treatment in the peristomal area.
  • Was pregnant or breast feeding
  • Participated in other interventional studies that could interfere with this one or had previously participated in this investigation.
  • Had a baseplate wear time of more than three days
  • Suffered from peristomal skin problems that precluded participation in the investigation (assessed by the investigation nurse)

About this study

To assess the functionality and safety of the test products and also assess the products ability to collect stool without interfering with the stoma.

Being tested
Coloplast Test A, Coloplast Test B, Own product, Coloplast Test C, Coloplast Test D

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Coloplast Test ADevice

    Coloplast Test A is a new ostomy appliance developed by Coloplast A/S

  • Coloplast Test BDevice

    Coloplast Test B is a newly developed ostomy appliance developed by Coloplast A/S

  • Own productDevice

    Own product is tested to get baseline results. Own product can be any 2-piece product that is commercially available. The manufactures can be Coloplast, Hollister, Convatec, Dansac, B. Braun and others.

  • Coloplast Test CDevice

    Coloplast Test C is a new ostomy appliance developed by Coloplast A/S

  • Coloplast Test DDevice

    Coloplast Test D is a new ostomy appliance developed by Coloplast A/S

Study groups in NCT02064231
Study groupRoleWhat they receive
Coloplast Test A, Coloplast Test B, Own productExperimentalThe subjects first test Coloplast Test A and thereafter Coloplast Test B and finally their own product for 14 days
Receives: Device: Coloplast Test A; Device: Coloplast Test B; Device: Own product
Coloplast Test C , Coloplast Test D, Own productExperimentalThe subjects first test Coloplast Test C and thereafter Coloplast Test D and finally their own product for 14 days
Receives: Device: Own product; Device: Coloplast Test C; Device: Coloplast Test D

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Degree of Leakage

    Degree of leakage is measured on a 24 point scale where 0 represents no leakage (best possible outcome) and 24 represents leakage on the whole plate (worst possible outcome).

    Measured: 14 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Feb 2014 (estimated)
  2. Study startJun 2012
  3. Primary completionAug 2012
  4. Study completionAug 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
28 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02064231
Sponsor's protocol ID
CP222
Status last verified
Aug 2020
First submitted
13 Feb 2014
Last updated
10 Sep 2020
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Coloplast Test A, Coloplast Test B and Own product in people with Ileostomy - Stoma, run by Coloplast A/S.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 4 Apr 2014). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Degree of Leakage (time frame: 14 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Sep 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT02064231 | AzTrials